1225932-01-3

Basic information

• Product Name: 3-(dimethylamino)-1-(3,4-dichlorobenzene)-1-propanol
• Synonyms: 3-(dimethylamino)-1-(3,4-dichlorobenzene)-1-propanol
• CAS NO: 1225932-01-3
• Molecular Weight: 248.152
• Mol File: 1225932-01-3.mol

Chemical Properties

• CAS DataBase Reference: 3-(dimethylamino)-1-(3,4-dichlorobenzene)-1-propanol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(dimethylamino)-1-(3,4-dichlorobenzene)-1-propanol(1225932-01-3)
• EPA Substance Registry System: 3-(dimethylamino)-1-(3,4-dichlorobenzene)-1-propanol(1225932-01-3)

Safety Data

• Hazardous Substances Data: 1225932-01-3(Hazardous Substances Data)

Upstream product

• 2642-63-9 3',4'-dichloroacetophenone 
• 50516-63-7 1-(3,4-dichlorophenyl)-3-(dimethylamino)-1-propanone 

Downstream Products

• 1198348-57-0 [3-(3,4-dichloro-phenyl)-3-tetrazol-2-yl-propyl]-dimethyl-amine 
• 1198348-86-5 [3-(3,4-dichloro-phenyl)-3-(5-methyl-tetrazol-2-yl)-propyl]-dimethyl-amine 
• 1198349-02-8 [3-(3,4-dichloro-phenyl)-3-[1,2,3]triazol-2-yl-propyl]-dimethyl-amine 
• 1346460-40-9 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-morpholinopropan-1-amine hydrochloride 
• 1346460-43-2 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(piperidin-1-yl)propan-1-amine hydrochloride 
• 1346460-39-6 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(piperazin-1-yl)propan-1-amine hydrochloride 
• 1346460-38-5 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(pyrrolidin-1-yl)propan-1-amine hydrochloride 
• 1198348-58-1 [3-(3,4-dichloro-phenyl)-3-tetrazol-2-yl-propyl]-methyl-amine 
• 1198348-59-2 (S)-[3-(3,4-dichloro-phenyl)-3-tetrazol-2-yl-propyl]-methyl-amine 

Relevant articles and documents

3-[(BENZO[D][1,3]DIOXOLAN-4-YL)-OXY]-3-ARYLPROPYLAMINE TYPE COMPOUNDS AND APPLICATIONS THEREOF

The present invention relates to 3-[(benzo[d][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine compounds of formula I or pharmaceutically acceptable salts thereof and use thereof. The compound may be used to prepare an antidepressant agent.

ARALKYL DIAMINE DERIVATIVES AND USES THEREOF AS ANTIDEPRESSANT

Aralkyl diamine derivative of the following formula, pharmaceutically acceptable salts or uses thereof as antidepressants. The derivatives have triplex inhibiting activities of the reuptake of 5-HT, dopamine and noradrenalin, which can be administered to the patients in need of such treatment in the form of compositions orally or injectedly et al.

Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors

A series of 3-aryl-3-azolylpropan-1-amines was prepared and screened for its capability of inhibiting monoamine reuptake. Analogs with nanomolar potency, good human in vitro microsomal stability, and low drug-drug interaction potential were described. In

3-Substituted Propanamine Compounds

Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are als

3-SUBSTITUTED PROPANAMINE COMPOUNDS

Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I) or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also